Status:
COMPLETED
Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Active Rheumatoid Arthritis
Eligibility:
MALE
18+ years
Phase:
PHASE3
Brief Summary
To compare the therapeutic and radiographic effects and safety between etanercept, methotrexate, and the etanercept/methotrexate combination in patients with rheumatoid arthritis.
Detailed Description
Etanercept is an injection administered under the skin twice weekly. Methotrexate is a tablet to be taken once weekly. Patients will not know which treatment they are on. Patients will need to meet th...
Eligibility Criteria
Inclusion
- Inclusion:
- \- Generally healthy of at least 18 years of age with active rheumatoid arthritis.
- Exclusion:
- \- A history or presence of clinically important medical disease.
Exclusion
Key Trial Info
Start Date :
October 1 2000
Trial Type :
INTERVENTIONAL
End Date :
October 1 2001
Estimated Enrollment :
615 Patients enrolled
Trial Details
Trial ID
NCT00393471
Start Date
October 1 2000
End Date
October 1 2001
Last Update
December 13 2023
Active Locations (88)
Enter a location and click search to find clinical trials sorted by distance.
1
St Leonards, New South Wales, Australia, 2065
2
Adelaide, Australia, 5000
3
Southport, Australia, 4215
4
Vienna, Austria, 1110